Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma.

MLA

Marxgut, Léa, et al. “Outcomes of Adjuvant Lymph Node Field Radiotherapy and Immunotherapy for Stage III Melanoma.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, vol. 28, no. 8, Dec. 2024, pp. 633–39. EBSCOhost, https://doi.org/10.1016/j.canrad.2024.03.006.

APA

Marxgut, L., Desagneaux, A., Bellier, A., Mouret, S., Charles, J., Laramas, M., & Verry, C. (2024). Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma. Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, 28(8), 633–639. https://doi.org/10.1016/j.canrad.2024.03.006

Chicago

Marxgut, Léa, Andréa Desagneaux, Alexandre Bellier, Stéphane Mouret, Julie Charles, Mathieu Laramas, and Camille Verry. 2024. “Outcomes of Adjuvant Lymph Node Field Radiotherapy and Immunotherapy for Stage III Melanoma.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique 28 (8): 633–39. doi:10.1016/j.canrad.2024.03.006.